Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
44.71
+0.87 (1.98%)
At close: Nov 25, 2025, 4:00 PM EST
43.90
-0.81 (-1.81%)
After-hours: Nov 25, 2025, 5:51 PM EST

Crinetics Pharmaceuticals Revenue

Crinetics Pharmaceuticals had revenue of $143.00K in the quarter ending September 30, 2025. In the year 2024, Crinetics Pharmaceuticals had annual revenue of $1.04M, down -74.11%.

Revenue (ttm)
$1.04M
Revenue Growth
-74.11%
P/S Ratio
2,763.92
Revenue / Employee
$3,513
Employees
437
Market Cap
4.24B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.04M-2.97M-74.11%
Dec 31, 20234.01M-724.00K-15.28%
Dec 31, 20224.74M3.66M339.42%
Dec 31, 20211.08M1.01M1,418.31%
Dec 31, 202071.00K-1.12M-94.05%
Dec 31, 20191.19M-1.24M-50.86%
Dec 31, 20182.43M383.00K18.73%
Dec 31, 20172.05M1.46M247.20%
Dec 31, 2016589.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings